Replies to post #23483 on Elite Pharmaceuticals Inc (ELTP)

[Attote]

If the results are so good, how is that the action has not rebounded ..?.
However I enclose some comments on the results and complete reading ..
"When compared to the comparable prior year period, Elite's revenues decreased 40%, from $1.0 million in revenues generated during the quarter ended June 30, 2011, the last quarter in which Elite manufactured and sold the Lodrane extended release products. Elite's operations generated $0.3 million negative cash flow during the quarter, compared with positive operating cash flows of $0.2 million for the comparable quarter of last year. These decreases in revenues and cash flows, when compared to the June 2011 quarter, were mainly the result of the removal of the Lodrane extended release products from the US market, pursuant to a directive from the US Food and Drug Administration (FDA) which applied to approximately 500 products, including the Lodrane extended release products. At the time of the FDA's directive, the Lodrane extended release products comprised 97% of Elite's revenues, and the new revenue streams, while growing, have not yet achieved the levels of the Lodrane extended release products that were discontinued during the June 2011 quarter."http://finance.yahoo.com/news/elite-pharmaceuticals-inc-reports-financial-202343280.html
Best regards.......